NVS Stock Recent News
NVS LATEST HEADLINES
Artificial intelligence (AI) spans above and beyond today's popular large language models (LLMs). OpenAI's ChatGPT-4 Turbo or even Anthropic's Claude 3 make for an impressive assistant for everyday tasks.
In the most recent trading session, Novartis (NVS) closed at $95.73, indicating a -0.52% shift from the previous trading day.
Novartis is an innovative drugmaker that delivers strong financial results. The Swiss pharmaceutical giant's dividend history is also impressive.
In the most recent trading session, Novartis (NVS) closed at $96.32, indicating a +0.42% shift from the previous trading day.
#Morningstar  #NovoNordisk #StockInvesting Managers of highly rated funds own these foreign stocks. Should you?
In the latest trading session, Novartis (NVS) closed at $95.92, marking a -1.39% move from the previous day.
A U.S. appeals court on Monday revived an antitrust lawsuit by Regeneron Pharmaceuticals against Novartis related to prescription treatments to address a condition that can lead to eye disorders including permanent blindness.
Novartis (NVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
In the most recent trading session, Novartis (NVS) closed at $99.77, indicating a -1.58% shift from the previous trading day.
Novartis (NVS) closed the most recent trading day at $101.37, moving +0.66% from the previous trading session.